Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-22

Clinical Trial Update: Efgartigimod for Consolidation Therapy in gMG

View source ↗

Summary

The document provides an update on a clinical trial evaluating efgartigimod as consolidation therapy for generalized myasthenia gravis, with the study not yet r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Efgartigimod (efgartigimod)

Snippet

Sponsor: Da, Yuwei, M.D. | Conditions: Myasthenia Gravis | Status: NOT_YET_RECRUITING